Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
Lancet Respir Med
; 10(6): 529-531, 2022 06.
Article
in English
| MEDLINE | ID: covidwho-2132824
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Tuberculosis
/
COVID-19
Type of study:
Observational study
Limits:
Humans
Language:
English
Journal:
Lancet Respir Med
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS